Early day motion tabled by primary sponsor Sandra Gidley (Liberal Democrat), on Thursday, 28 February 2008, in the House of Commons. It is signed by 94 members in total.
WET AGE RELATED MACULAR DEGENERATION
That this House welcomes the announcement by the National Institute for Health and Clinical Excellence (NICE) of a review of its earlier appraisal consultation document regarding anti-VEGF treatments for wet age related macular degeneration (wet AMD); acknowledges that allocation of treatment according to the latest appraisal consultation document could potentially save the sight of as many as 26,000 patients per annum; welcomes the level of co-operation between NICE, the Royal National Institute for the Blind and members of the pharmaceutical industry in bringing about a satisfactory solution; looks forward to full guidance on anti-VEGF treatments for patients with wet AMD being published by NICE; and hopes that this guidance will be implemented as swiftly as possible by local primary care trusts.
Secondary information
- Type
- Early day motion
- Reference
- 1079
- Session
- 2007-08
- Other sponsors
- Adrian Bailey
- Doug Naysmith
- Richard Taylor
- Linda Riordan
- David Heath
- Subjects
- Health Health services Diseases Expenditure Medicine
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-10-06 20:29:02 +0100
- URI
- http://data.parliament.uk/edms/35280
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/35280
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/35280